Literature DB >> 19582483

Locus heterogeneity of Dent's disease: OCRL1 and TMEM27 genes in patients with no CLCN5 mutations.

Enrica Tosetto1, Maria Addis, Gianluca Caridi, Cristiana Meloni, Francesco Emma, Gianluca Vergine, Gilda Stringini, Teresa Papalia, Giancarlo Barbano, Gian Marco Ghiggeri, Laura Ruggeri, Nunzia Miglietti, Angela D Angelo, Maria Antonietta Melis, Franca Anglani.   

Abstract

Dent's disease is an X-linked renal tubulopathy caused by mutations mainly affecting the CLCN5 gene. Defects in the OCRL1 gene, which is usually mutated in patients with Lowe syndrome, have recently been shown to lead to a Dent-like phenotype, called Dent's disease 2. About 25% of Dent's disease patients do not carry CLCN5/OCRL1 mutations. The CLCN4 and SLC9A6 genes have been investigated, but no mutations have been identified. The recent discovery of a novel mediator of renal amino acid transport, collectrin (the TMEM27 gene), may provide new insight on the pathogenesis of Dent's disease. We studied 31 patients showing a phenotype resembling Dent's disease but lacking any CLCN5 mutations by direct sequencing of the OCRL1 and TMEM27 genes. Five novel mutations, L88X, P161HfsX167, F270S, D506N and E720D, in the OCRL1 gene, which have not previously been reported in patients with Dent's or Lowe disease, were identified among 11 patients with the classical Dent's disease phenotype. No TMEM27 gene mutations were discovered among 26 patients, 20 of whom had an incomplete Dent's disease phenotype. Our findings confirm that OCRL1 is involved in the functional defects characteristic of Dent's disease and suggest that patients carrying missense mutations in exons where many Lowe mutations are mapped may represent a phenotypic variant of Lowe syndrome.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19582483     DOI: 10.1007/s00467-009-1228-4

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  29 in total

1.  Organic-aciduria, decreased renal ammonia production, hydrophthalmos, and mental retardation; a clinical entity.

Authors:  C U LOWE; M TERREY; E A MacLACHLAN
Journal:  AMA Am J Dis Child       Date:  1952-02

2.  Physical mapping and genomic structure of the Lowe syndrome gene OCRL1.

Authors:  R L Nussbaum; B M Orrison; P A Jänne; L Charnas; A C Chinault
Journal:  Hum Genet       Date:  1997-02       Impact factor: 4.132

3.  Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.

Authors:  S S Wang; O Devuyst; P J Courtoy; X T Wang; H Wang; Y Wang; R V Thakker; S Guggino; W B Guggino
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

4.  Membrane targeting and activation of the Lowe syndrome protein OCRL1 by rab GTPases.

Authors:  Noora Hyvola; Aipo Diao; Eddie McKenzie; Alison Skippen; Shamshad Cockcroft; Martin Lowe
Journal:  EMBO J       Date:  2006-08-10       Impact factor: 11.598

5.  Essential role for collectrin in renal amino acid transport.

Authors:  Ursula Danilczyk; Renu Sarao; Christine Remy; Chahira Benabbas; Gerti Stange; Andreas Richter; Sudha Arya; J Andrew Pospisilik; Dustin Singer; Simone M R Camargo; Victoria Makrides; Tamara Ramadan; Francois Verrey; Carsten A Wagner; Josef M Penninger
Journal:  Nature       Date:  2006-12-13       Impact factor: 49.962

6.  Human non-synonymous SNPs: server and survey.

Authors:  Vasily Ramensky; Peer Bork; Shamil Sunyaev
Journal:  Nucleic Acids Res       Date:  2002-09-01       Impact factor: 16.971

7.  X-linked recessive nephrolithiasis with renal failure.

Authors:  P A Frymoyer; S J Scheinman; P B Dunham; D B Jones; P Hueber; E T Schroeder
Journal:  N Engl J Med       Date:  1991-09-05       Impact factor: 91.245

8.  Renal manifestations of Dent disease and Lowe syndrome.

Authors:  Hee Yeon Cho; Bum Hee Lee; Hyun Jin Choi; Il Soo Ha; Yong Choi; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2007-11-24       Impact factor: 3.714

9.  A common molecular basis for three inherited kidney stone diseases.

Authors:  S E Lloyd; S H Pearce; S E Fisher; K Steinmeyer; B Schwappach; S J Scheinman; B Harding; A Bolino; M Devoto; P Goodyer; S P Rigden; O Wrong; T J Jentsch; I W Craig; R V Thakker
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

10.  All known patient mutations in the ASH-RhoGAP domains of OCRL affect targeting and APPL1 binding.

Authors:  Heather J McCrea; Summer Paradise; Livia Tomasini; Maria Addis; Maria Antonietta Melis; Maria Antonietta De Matteis; Pietro De Camilli
Journal:  Biochem Biophys Res Commun       Date:  2008-02-26       Impact factor: 3.575

View more
  13 in total

1.  Suppression of intestinal calcium entry channel TRPV6 by OCRL, a lipid phosphatase associated with Lowe syndrome and Dent disease.

Authors:  Guojin Wu; Wei Zhang; Tao Na; Haiyan Jing; Hongju Wu; Ji-Bin Peng
Journal:  Am J Physiol Cell Physiol       Date:  2012-02-29       Impact factor: 4.249

2.  Incomplete cryptic splicing by an intronic mutation of OCRL in patients with partial phenotypes of Lowe syndrome.

Authors:  Eiji Nakano; Amine Yoshida; Yudai Miyama; Tomoo Yabuuchi; Yuko Kajiho; Shoichiro Kanda; Kenichiro Miura; Akira Oka; Yutaka Harita
Journal:  J Hum Genet       Date:  2020-05-19       Impact factor: 3.172

3.  OCRL1 mutation in a boy with Dent disease, mild mental retardation, but without cataracts.

Authors:  Vladimir J Lozanovski; N Ristoska-Bojkovska; P Korneti; Z Gucev; V Tasic
Journal:  World J Pediatr       Date:  2011-08-07       Impact factor: 2.764

4.  Clinical and laboratory features of Macedonian children with OCRL mutations.

Authors:  Velibor Tasic; Vladimir J Lozanovski; Petar Korneti; Nadica Ristoska-Bojkovska; Vesna Sabolic-Avramovska; Zoran Gucev; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2011-01-20       Impact factor: 3.714

5.  Characterization of 28 novel patients expands the mutational and phenotypic spectrum of Lowe syndrome.

Authors:  Florian Recker; Marcin Zaniew; Detlef Böckenhauer; Nunzia Miglietti; Arend Bökenkamp; Anna Moczulska; Anna Rogowska-Kalisz; Guido Laube; Valerie Said-Conti; Belde Kasap-Demir; Anna Niemirska; Mieczysław Litwin; Grzegorz Siteń; Krystyna H Chrzanowska; Małgorzata Krajewska-Walasek; Sidharth K Sethi; Velibor Tasic; Franca Anglani; Maria Addis; Anna Wasilewska; Maria Szczepańska; Krzysztof Pawlaczyk; Przemysław Sikora; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2014-12-06       Impact factor: 3.714

6.  An atypical Dent's disease phenotype caused by co-inheritance of mutations at CLCN5 and OCRL genes.

Authors:  Maria Addis; Cristiana Meloni; Enrica Tosetto; Monica Ceol; Rosalba Cristofaro; Maria Antonietta Melis; Paolo Vercelloni; Dorella Del Prete; Giuseppina Marra; Franca Anglani
Journal:  Eur J Hum Genet       Date:  2012-10-10       Impact factor: 4.246

Review 7.  Hereditary causes of kidney stones and chronic kidney disease.

Authors:  Vidar O Edvardsson; David S Goldfarb; John C Lieske; Lada Beara-Lasic; Franca Anglani; Dawn S Milliner; Runolfur Palsson
Journal:  Pediatr Nephrol       Date:  2013-01-20       Impact factor: 3.714

8.  Lowe syndrome patient cells display mTOR- and RhoGTPase-dependent phenotypes alleviated by rapamycin and statins.

Authors:  Kayalvizhi Madhivanan; Swetha Ramadesikan; Wen-Chieh Hsieh; Mariana C Aguilar; Claudia B Hanna; Robert L Bacallao; R Claudio Aguilar
Journal:  Hum Mol Genet       Date:  2020-06-27       Impact factor: 6.150

9.  Recognition of the F&H motif by the Lowe syndrome protein OCRL.

Authors:  Michelle Pirruccello; Laura E Swan; Ewa Folta-Stogniew; Pietro De Camilli
Journal:  Nat Struct Mol Biol       Date:  2011-06-12       Impact factor: 15.369

10.  Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene.

Authors:  Eleni Drosataki; Sevasti Maragkou; Kleio Dermitzaki; Ioanna Stavrakaki; Dimitra Lygerou; Helen Latsoudis; Christos Pleros; Ioannis Petrakis; Ioannis Zaganas; Kostas Stylianou
Journal:  BMC Nephrol       Date:  2022-05-12       Impact factor: 2.585

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.